Cargando…
Levels of uPA and PAI-1 in breast cancer and its correlation to Ki67-index and results of a 21-multigene-array
BACKGROUND: Conventional parameters including Ki67, hormone receptor and Her2/neu status are used for risk stratification for breast cancer. The serine protease urokinase plasminogen activator (uPA) and the plasminogen activator inhibitor type-1 (PAI-1) play an important role in tumour invasion and...
Autores principales: | Völker, Hans-Ullrich, Weigel, Michael, Strehl, Annette, Frey, Lea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119317/ https://www.ncbi.nlm.nih.gov/pubmed/30170623 http://dx.doi.org/10.1186/s13000-018-0737-5 |
Ejemplares similares
-
Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers
por: Deluche, Elise, et al.
Publicado: (2017) -
Practical Consequences Resulting from the Analysis of a 21-Multigene Array in the Interdisciplinary Conference of a Breast Cancer Center
por: Voelker, Hans-Ullrich, et al.
Publicado: (2018) -
Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014) -
Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer
por: Märkl, Bruno, et al.
Publicado: (2019) -
Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study
por: Märkl, Bruno, et al.
Publicado: (2017)